Xiaoran Han

1.7k total citations · 1 hit paper
22 papers, 1.2k citations indexed

About

Xiaoran Han is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Xiaoran Han has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Surgery. Recurrent topics in Xiaoran Han's work include Ubiquitin and proteasome pathways (8 papers), Protein Degradation and Inhibitors (7 papers) and Multiple Myeloma Research and Treatments (3 papers). Xiaoran Han is often cited by papers focused on Ubiquitin and proteasome pathways (8 papers), Protein Degradation and Inhibitors (7 papers) and Multiple Myeloma Research and Treatments (3 papers). Xiaoran Han collaborates with scholars based in China, United States and Hong Kong. Xiaoran Han's co-authors include Kaifeng Wang, Zu‐Yao Yang, Diane Threapleton, Yuelun Zhang, Jin-Qiu Yuan, Xiaohong Fu, Chen Mao, Jin-Ling Tang, Yue Xiong and Jian Jin and has published in prestigious journals such as Journal of the American Chemical Society, Molecular Cell and Cancer Research.

In The Last Decade

Xiaoran Han

20 papers receiving 1.2k citations

Hit Papers

The prevalence of EGFR mutation in patients with non-smal... 2016 2026 2019 2022 2016 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis
    2016 537 citations Yuelun Zhang, Jin-Qiu Yuan et al. Oncotarget profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoran Han China 12 707 595 517 167 155 22 1.2k
Yuqian Yan United States 19 1.0k 1.4× 392 0.7× 315 0.6× 114 0.7× 278 1.8× 37 1.4k
Amy Weise United States 19 438 0.6× 530 0.9× 259 0.5× 59 0.4× 102 0.7× 69 946
David James VanderWeele United States 15 485 0.7× 300 0.5× 355 0.7× 45 0.3× 262 1.7× 57 1.0k
Rama Krishna Kancha India 14 286 0.4× 365 0.6× 304 0.6× 82 0.5× 150 1.0× 37 761
D. Gandara United States 11 478 0.7× 377 0.6× 203 0.4× 59 0.4× 83 0.5× 26 837
Silvia Rita Vitale Italy 16 429 0.6× 251 0.4× 182 0.4× 169 1.0× 333 2.1× 46 978
Theresa A. Mays United States 10 773 1.1× 477 0.8× 218 0.4× 65 0.4× 137 0.9× 15 1.2k
Lauren M. Thorpe United States 5 862 1.2× 341 0.6× 196 0.4× 79 0.5× 201 1.3× 7 1.2k
Teresa Di Desidero Italy 24 421 0.6× 542 0.9× 253 0.5× 28 0.2× 200 1.3× 52 1.1k
Alessandro Perez Italy 15 301 0.4× 272 0.5× 206 0.4× 57 0.3× 181 1.2× 41 693

Countries citing papers authored by Xiaoran Han

Since Specialization
Citations

This map shows the geographic impact of Xiaoran Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoran Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoran Han more than expected).

Fields of papers citing papers by Xiaoran Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoran Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoran Han. The network helps show where Xiaoran Han may publish in the future.

Co-authorship network of co-authors of Xiaoran Han

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoran Han. A scholar is included among the top collaborators of Xiaoran Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoran Han. Xiaoran Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Mingjie, Jin Wu, Hebo Wang, et al.. (2025). Rimegepant for the acute treatment of migraine: A phase 3, multicenter, open-label, long-term safety and effectiveness study in adults from China. Cephalalgia. 45(10). 2235416742–2235416742. 1 indexed citations
2.
3.
4.
An, Cuihua, Chao Wang, Xiaoran Han, et al.. (2025). H2-induced Pt segregation constructs the Pt@PtNi@Pt nanowires for promoted hydrogen evolution. Applied Surface Science. 700. 163226–163226. 1 indexed citations
5.
Han, Xiaoran, et al.. (2025). Deciphering the mechanisms of PARP inhibitor resistance in prostate cancer: Implications for precision medicine. Biomedicine & Pharmacotherapy. 185. 117955–117955. 2 indexed citations
6.
Wu, Shuai, et al.. (2025). Iron Doping Optimizes CoFeCr LDH for Ultrasound‐Assisted Water Splitting. ChemCatChem. 17(11). 1 indexed citations
7.
8.
Wu, Xiaojie, Jicheng Yu, Jeffrey Wang, et al.. (2024). A Randomized, Open-Label, Phase I, Single-Dose Study of Antisense Oligonucleotide, Vupanorsen, in Chinese Adults with Elevated Triglycerides. Drugs in R&D. 24(2). 253–262. 1 indexed citations
9.
Hu, Mengnan, Miao Lin, Xiaoran Han, et al.. (2022). ALK fusion promotes metabolic reprogramming of cancer cells by transcriptionally upregulating PFKFB3. Oncogene. 41(40). 4547–4559. 11 indexed citations
10.
Xiong, Yan, Yue Zhong, Xiaobao Yang, et al.. (2022). Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets. Journal of the American Chemical Society. 144(49). 22622–22632. 84 indexed citations
11.
Chen, Liqun, Yanke Chen, Chunyan Zhang, et al.. (2020). Discovery of First-In-Class Potent and Selective Tropomyosin Receptor Kinase Degraders. Journal of Medicinal Chemistry. 63(23). 14562–14575. 39 indexed citations
12.
Han, Xiaoran, Naoya Sasaki, Sarah Jackson, et al.. (2020). CRL4 DCAF1/VprBP E3 ubiquitin ligase controls ribosome biogenesis, cell proliferation, and development. Science Advances. 6(51). 31 indexed citations
13.
Han, Xiaoran, Liqun Chen, Weihua Yu, et al.. (2020). Discovery of Selective Small Molecule Degraders of BRAF-V600E. Journal of Medicinal Chemistry. 63(8). 4069–4080. 50 indexed citations
14.
Han, Xiaoran, Liqun Chen, Chengwei Zhang, et al.. (2020). Abstract 5331: Targeted protein degradation for the treatment of TRK fusion-driven cancers. Cancer Research. 80(16_Supplement). 5331–5331. 1 indexed citations
15.
Fan, Yonggang, Tian Guo, Xiaoran Han, et al.. (2019). Paricalcitol accelerates BACE1 lysosomal degradation and inhibits calpain-1 dependent neuronal loss in APP/PS1 transgenic mice. EBioMedicine. 45. 393–407. 23 indexed citations
16.
Zhang, Chengwei, Xiaoran Han, Xiaobao Yang, et al.. (2018). Proteolysis Targeting Chimeras (PROTACs) of Anaplastic Lymphoma Kinase (ALK). European Journal of Medicinal Chemistry. 151. 304–314. 184 indexed citations
17.
Zha, Zhengyu, Xiaoran Han, Matthew D. Smith, et al.. (2016). Hypertension-associated C825T polymorphism impairs the function of Gβ3 to target GRK2 ubiquitination. Cell Discovery. 2(1). 16005–16005. 13 indexed citations
18.
Han, Xiaoran, Zheng Zha, Xu Feng, et al.. (2016). KDM2B/FBXL10 targets c-Fos for ubiquitylation and degradation in response to mitogenic stimulation. Oncogene. 35(32). 4179–4190. 38 indexed citations
19.
Zhang, Yuelun, Jin-Qiu Yuan, Kaifeng Wang, et al.. (2016). The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget. 7(48). 78985–78993. 537 indexed citations breakdown →
20.
Zha, Zhengyu, Xiaoran Han, Matthew D. Smith, et al.. (2015). A Non-Canonical Function of Gβ as a Subunit of E3 Ligase in Targeting GRK2 Ubiquitylation. Molecular Cell. 58(5). 794–803. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuqian Yan Breakdown of academic impact, for papers by Amy Weise Breakdown of academic impact, for papers by David James VanderWeele Breakdown of academic impact, for papers by Rama Krishna Kancha Breakdown of academic impact, for papers by D. Gandara Breakdown of academic impact, for papers by Silvia Rita Vitale Breakdown of academic impact, for papers by Theresa A. Mays Breakdown of academic impact, for papers by Lauren M. Thorpe Breakdown of academic impact, for papers by Teresa Di Desidero Breakdown of academic impact, for papers by Alessandro Perez
Rankless by CCL
2026